HMG

HMG, or human menopausal gonadotropin, is a research-grade injectable compound that combines the biological activities of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). This unique formulation is derived from the urine of postmenopausal women and has been extensively studied for its role in the stimulation of the reproductive axis, making it a valuable tool in fertility research and reproductive endocrinology.

The dual activity of HMG facilitates the development and maturation of ovarian follicles, thereby enhancing ovulation and supporting assisted reproductive technologies. Researchers utilize HMG to investigate various aspects of fertility, including ovarian response, hormonal regulation, and the mechanisms underlying reproductive health. Its applications extend to studies on polycystic ovary syndrome (PCOS), hormonal therapies, and the optimization of in vitro fertilization (IVF) protocols.

As a critical component in the field of reproductive research, HMG serves as a model for understanding the complex interactions between gonadotropins and their effects on the reproductive system. Its use in controlled laboratory settings allows for the exploration of therapeutic strategies aimed at addressing infertility and related disorders.

For research and laboratory use only. Not for human consumption.